Supernus Pharmaceuticals, Inc. (SUPN) NASDAQ

51.84

+0.39(+0.76%)

Updated at January 14 11:12AM

Currency In USD

Valuation

Market Cap1.99B
Enterprise Value1.96B
P/E Ratio-152.13
PEG Ratio1.19
Price/Sales Ratio0.01
Price/Book Ratio0
Enterprise/Revenue-0.61
Enterprise/EBITDA-2,719.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0
Operating Margin-0.31

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue661.82M
Revenue/Share3,405.54
Gross Profit583.91M
EBITDA178.28M
Net Income73.86M
Diluted EPS1.32

Balance Sheet

Total Cash281.16M
Total Cash/Share4,971.64
Total Debt31.42M
Total Debt/Equity0.03
Current Ratio1.8
Book Value Per Share18,560.85

Price History

52-Week Change36.28
52-Week High57.65
52-Week Low29.16
Moving Average 50 Days48.13
Moving Average 200 Days40.73

Statistics

Average Volume800,024
Shares Outstanding55.97M
% Held by Institutions102.96

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A